October 28,  2021

09:00 - 09:30 BST

This lecture will provide an overview of how countries in Europe and Central Asia are progressing toward the Sustainable Development Goals (SDG) as they pertain to HIV/AIDS. Although the lecture will highlight where progress has been made, the focus will be on where the major challenges remain and what gaps need to be addressed in order to put ourselves “on the path to zero”.

Speaker: Teymur Noori, Sweden

October 28, 2021

09:35 - 10:05 BST

Both HIV and SARS-CoV-2 caused worldwide pandemics warranting the rapid development and deployment of vaccines.  While several highly effective vaccines against SARS-CoV-2 were developed in record time, no effective vaccine against HIV is available despite almost 35 years of research and development.  In this talk, I will describe why the development pathways for these two viruses differed so greatly, but also how the vaccine efforts in HIV laid much of the groundwork for the incredible success of SARS-CoV-2 vaccine development.  I will also speculate on how the success of SARS-CoV-2 vaccines may help accelerate HIV vaccine development going forward.

Speaker: Richard Koup, United States

October 29, 2021

09:00 - 09:30 BST

Weight gain following antiretroviral therapy initiation is common and may represent a "return to health" for some patients. However, others experience severe weight gain that exceeds what could reasonably be considered healthy. Simultaneously, worldwide obesity prevalence is increasing. Recently, some integrase strand transfer inhibitors and tenofovir alafenamide have been implicated in greater weight gain than other antiretroviral regimens. Mechanisms and clinical significance of any differential weight gain, however, are not well understood. This talk will review the available literature on this topic, identify gaps and propose future directions.   

Speaker: Jordan E. Lake, United States